Search hospitals > Missouri > Kansas City
Saint Luke's Hospital of Kansas City
Claim this profileKansas City, Missouri 64111
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Heart Failure
Conducts research for Stroke
Conducts research for Lung Cancer
437 reported clinical trials
44 medical researchers
Summary
Saint Luke's Hospital of Kansas City is a medical facility located in Kansas City, Missouri. This center is recognized for care of Cancer, Breast Cancer, Heart Failure, Stroke, Lung Cancer and other specialties. Saint Luke's Hospital of Kansas City is involved with conducting 437 clinical trials across 534 conditions. There are 44 research doctors associated with this hospital, such as Michael Gibson, Timothy Pluard, Janakiraman Subramanian, and Keith Allen, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage II
Stage III
2Breast Cancer
Global LeaderHER2 negative
ER positive
HER2 positive
Top PIs
Michael GibsonVanderbilt University/Ingram Cancer Center4 years of reported clinical research
Studies Cancer
Studies Squamous Cell Carcinoma
17 reported clinical trials
36 drugs studied
Timothy PluardSaint Luke's Cancer Institute LLC1 year of reported clinical research
Studies Breast Cancer
Studies Tumors
13 reported clinical trials
23 drugs studied
Janakiraman SubramanianSaint Luke's Hospital of Kansas City5 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
10 reported clinical trials
20 drugs studied
Keith Allen, MDSt. Luke's Hospital of Kansas City2 years of reported clinical research
Studies Bleeding
Studies Mitral Valve Regurgitation
8 reported clinical trials
15 drugs studied
Clinical Trials running at Saint Luke's Hospital of Kansas City
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Stroke
Ischemic Stroke
Pancreatic Cancer
Pancreatic Carcinoma
Cardiomyopathy
Cancer
Amyloidosis
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Saint Luke's Hospital of Kansas City?
Saint Luke's Hospital of Kansas City is a medical facility located in Kansas City, Missouri. This center is recognized for care of Cancer, Breast Cancer, Heart Failure, Stroke, Lung Cancer and other specialties. Saint Luke's Hospital of Kansas City is involved with conducting 437 clinical trials across 534 conditions. There are 44 research doctors associated with this hospital, such as Michael Gibson, Timothy Pluard, Janakiraman Subramanian, and Keith Allen, MD.
Where is Saint Luke's Hospital of Kansas City located?
**Saint Luke's Hospital of Kansas City**
- **Address:** 4401 Wornall Rd, Kansas City, MO 64111.
- **Parking:** Free patient and visitor parking available in designated areas, including Lot 13 and Parking A at 43rd Street, Entrance C.
Who should I call to ask about financial aid or insurance network?
**Saint Luke's Hospital of Kansas City - Financial Assistance and Insurance Contact Information**
**Financial Assistance:**
- **Phone:** 816-932-5678 or 888-581-9401 (toll-free)
- **Email:** slhsbilling@saintlukeskc.org
- **Website:** [Saint Luke's Financial Assistance](https://www.saintlukeskc.org/saint-lukes-hospital-kansas-city-financial-assistance)
**Insurance:**
- **Phone:** 832-355-3081
- **Website:** [St. Luke's Insurance Information](https://www.stlukeshealth.org/patients-visitors/patients/billing-insurance)
**General Billing Inquiries:**
- **Phone:** 314-576-8100 or 888-924-9200 (toll-free)
- **Fax:** 314-576-8180
- **Address:** St. Luke's Hospital, Attn: Billing Department, 232 S. Woods Mill Road, Chesterfield, MO 63017
For assistance with financial aid applications, insurance queries, and billing concerns, please use the above contacts.
What insurance does Saint Luke's Hospital of Kansas City accept?
Saint Luke's Hospital of Kansas City accepts a wide range of insurance plans, ensuring comprehensive coverage for various patient needs. Among the accepted insurances are Aetna (including Aetna Select HMO, Aetna Choice POS II, and Aetna Missouri Preferred), Blue Cross Blue Shield (including Pathway X, Blue Choice Preferred, and Blue Access), Cigna, Humana, United Healthcare, and many more, covering both national and local plans. It's advised to verify with your insurance carrier that Saint Luke's is an in-network facility and that the planned services are covered by your plan before scheduling any appointments.
What awards or recognition has Saint Luke's Hospital of Kansas City received?
Saint Luke's Hospital of Kansas City is renowned for its healthcare excellence, having been ranked 35th nationally by Consumer's Checkbook in 2002. The hospital boasts a dedicated Office of Research Services, supporting a wide range of research activities. Its research mission emphasizes clinical, translational, and outcomes research to enhance patient care and population health.